<DOC>
	<DOCNO>NCT01426997</DOCNO>
	<brief_summary>To facilitate development personalize approach treatment patient major depression , study design elaborate clinical neurobiological phenotype depress patient increased inflammation . The data obtain proposal allow investigator test hypothesis depression inflammation interact elaborate relatively discreet phenotype warrant individualize approach diagnosis treatment patient depression . Moreover , identification specific environmental risk factor inflammation foster elaboration preventative strategy patient risk .</brief_summary>
	<brief_title>Phenotype Depression Study</brief_title>
	<detailed_description>One hundred thiry-five patient major depression diagnose base DSM-IV TR criterion age 21 65 ( male , female minority ) recruit . Forty-five patient high inflammation define CRP &gt; 3 mg/L enrol along 45 depressed patient medium inflammation ( CRP=1-3mg/L ) 45 depressed patient low inflammation ( CRP &lt; 1mg/L ) complete 2 night inpatient stay Emory University Hospital 's research unit , Atlanta Clinical Translational Science Institute ( ACTSI ) . Participants undergo psychiatric neurocognitive assessment , sleep study blood cerebral spinal fluid ( CSF ) sampling .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<criteria>age 2165 year include male , female minority diagnosis DSMIV major depression Bipolar I II current episode depression HDRS17 &gt; 20 HDRS24 &gt; 24 negative pregnancy test woman childbearing potential breast feed stable current dose psychotropic medication free psychotropic medication 4 week prior EUH CIN admission ( 8 week fluoxetine ) suicide attempt within six month screen evidence untreated poorly control endocrine , cardiovascular , pulmonary , hematological , renal , neurological disease history CNS trauma active seizure disorder require medication unless otherwise approve principle investigator autoimmune inflammatory disorder kind chronic infection ( e.g . hepatitis B C HIV ) chronic use agent know affect immune system include glucocorticoid therapy within past 1 year , methotrexate within past 1 year , chemotherapy kind ( past present ) , immunotherapy kind ( past present ) , aspirin nonsteroidal antiinflammatory drug ( NSAIDs ) ( within past 2 week ) statin ( within past 1 month ) unless otherwise approve principle investigator hemoglobinopathy ( e.g . thalassemia ) positive pregnancy test organ transplant cancer type score &lt; 28 Mini Mental Status Exam ( MMSE ) unless otherwise approve principle investigator meet criteria schizophrenia ( Given overlap generalize anxiety disorder ( GAD ) major depression , GAD exclusionary ) current eat disorder active abuse alcohol illicit/prescription drug within past year unless otherwise approve principle investigator . MGHS &gt; 3 unless otherwise approve principle investigator BMI &gt; 40 unless otherwise approve principle investigator active suicidal intent plan score &gt; 2 HDRS suicide item ( item # 3 ) . condition opinion investigator would make patient unsuitable enrollment , could interfere participate complete protocol</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Major Depressive Disorder</keyword>
	<keyword>Depression</keyword>
</DOC>